The first of the planned 24 participants in the Cohort Expansion Phase (Phase II) of the SECuRE trial has been treated with their first dose of 8 GBq of 67 Cu-SAR-bisPSMA.This follows the recent ...

Serkan Oray from UCB shares why the autoinjector pen format is booming, the importance of a patient-centric design, and how ...

HIGHLIGHTS The first of the planned 24 participants in the Cohort Expansion Phase (Phase II) of the SECuRE trial has been treated with their first dose of 8 GBq of ...

Serkan Oray from UCB shares why the autoinjector pen format is booming, the importance of a patient-centric design, and how to get a design concept off the ground.

This innovative tech collaboration addresses emotional, logistical and financial challenges associated with international clinical trial recruitme ...

In racially and socioeconomically marginalized pediatric patients there are significant inequities in the incidence of HER behavioral flags.

Novartis Canada is pleased to announce that Fabhalta® (iptacopan capsules) is now available across Canada for adult patients ...

U.S. FDA Grants Full Approval of VITRAKVI® (larotrectinib) for Adult and Pediatric Patients with NTRK Gene Fusion-Positive ...

Private, personal, highly-sensitive patient data labelled on an envelope’s exterior for all to see enroute. In an era of identity theft. In a home that requires paper accommodations due to health. Our ...

Schreiner MediPharm, a Germany-based global provider of functional label solutions for the healthcare industry, has ...